JJIJ
PNT

Johnson & Johnson Innovation - JJDC’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$10.3M Buy
+1,000,000
New +$10.2M 1.05% 10

Other funds holding PNT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's PNT Position: Q2 2021 in Review

Johnson & Johnson Innovation - JJDC opened a new position in POINT Biopharma Global Inc. Common Stock (PNT) in Q2 2021: 1,000,000 shares worth $10.3M. The stake represents 1.05% of the portfolio and ranks #10 among its holdings.

21 funds tracked by Wall St. Rank hold PNT as of Q2 2021.

  • Johnson & Johnson Innovation - JJDC held 1,000,000 shares of POINT Biopharma Global Inc. Common Stock worth $10.3M as of Q2 2021.
  • POINT Biopharma Global Inc. Common Stock was a new Johnson & Johnson Innovation - JJDC position in Q2 2021.
  • POINT Biopharma Global Inc. Common Stock made up 1.05% of Johnson & Johnson Innovation - JJDC's portfolio in Q2 2021, its #10 holding.
  • 21 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q2 2021.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q2 2021, filed 3 Aug 2021.